Manufacturing Practice (GMP) facility for cell and vector production; development of a clinician scientist training programme in Ireland; drafting the College of Medicine research strategy with a major goal of recruiting future faculty with relevance to regenerative medicine; leveraging of faculty appointments to support the development of regenerative medicine; establishment of robust industrial partnerships based on strong interactions with the Industrial Development Agency and Enterprise Ireland; and the formal recognition of the importance of research to Galway University Hospital. In addition, Prof O'Brien has played a major role in the outreach and education activities of REMEDI including primary and secondary school programmes, public outreach and interaction with policy makers."
Prof. O'Brien has published 155 original papers in peerreviewed journals, 40 of these being review articles. He has contributed chapters to nine books on topics relating to vascular gene transfer and has been invited to present his research at 118 national and international scientific conferences. He is an author on three patent applications and five invention disclosures. He is the Director of the new MSc in regenerative medicine at NUI Galway with 15 students in the inaugural year and has supervised 4 of the 6 students who have graduated with PhD degrees from REMEDI in the past 18 months. He is a co-founder of a spin out company, Procure Laboratories.
Professor O'Brien is currently working on the use of mesenchymal stem cells and repaired endothelial progenitor cells in diabetic complications such as critical limb ischemia.
References: From 2012, he and his co-investigators have been awarded more than €1million in the area of dystonia, testament to his ability. His research interests include multiple sclerosis, hereditary spastic paraplegia and dystonia.
He has 280 peer-reviewed publications with an h-index of 47, i10-index of 122 and 11,345 citations in Google Scholar.
References: Prof. Mary Cannon is involved in youth mental health both nationally and internationally and is a member of the ACAMH National Special Interest Group in Youth Mental Health since it was founded. This group was instrumental in the development of the International Declaration on Youth Mental Health.
She has served on the editorial boards of Schizophrenia Bulletin and the British Journal of Psychiatry.
Professor Cannon has 520 publications with an h-index of 52, i-10 index of 100 and 13,807 citations in Google Scholar (September 2017).
References:
Collaborating Centre and Distinguished Research Fellow at Curtin University in Perth. He has many honours, including the 2014 Aramark Alumni Award for Science at NUI Galway.
Professor O'Gara focused on the molecular basis of microbe host interactions using functional genomic and molecular-microbial ecology techniques to tease out the pathogen host interactions in medical microbiology. Research into molecular and functional genomic approaches are also being applied to understand the role of marine microorganisms in ecosystem function. Additionally, his group are exploiting marine-derived bioactive components for biotechnological application.
His group have discovered a bioblocker to block the formation of biofilms guarding microorganisms and allow antibiotics to be more effective. This process is being patented.
Professor O'Gara has an h-index of 57 and an i10-index of 193 with 11,793 citations in Google Scholar (September 2017).
